MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. APGE
5. USO
6. GOOGL
7. MU
8. HOOD
9. DFTX
10. RGNX

Go back to MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program

Amgen and Biogen 'look attractive' - HSBC

September 6, 2023 11:39 AM EDT

HSBC initiated coverage of 11 US biopharmaceutical and healthcare stocks in a note to clients on Wednesday.

Analyst Morten Herholdt assigned Actinium Pharma (NYSE: ATNM), Amgen (NASDAQ: AMGN), Biogen (NASDAQ: BIIB), Bluebird... More